ArticleCell reports. Medicine2024

Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy.

Michael St Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.